QQQ $ 454.82 $ 2.54 (0.56 %)
DIA $ 398.57 $ -0.71 (-0.18 %)
SPY $ 530.36 $ 3.51 (0.67 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" of the "Company"), a biopharmaceutical company ...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company ...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company ...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company ...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company ...

Core News & Articles

 FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company...

Core News & Articles

Launch in the Consumer Market to be Led by Former Executives from Coca-Cola and Celsius Holdings TORONTO, ON / ACCESSWIRE / Au...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical compa...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical compa...

Core News & Articles

Company Seeking to Initiate Phase 1 Clinical Trial for its First-in-Class Multiple Sclerosis Drug Candidate FSD Pharma Inc. (N...

Core News & Articles

FSD Pharma Inc Announces Three Key Additions to Scientific and Clinical Expert Committee FSD Pharma Inc Announces It Is Invest...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical compan...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to ...

Core News & Articles

FSD Pharma Files Investigational New Drug Application ("IND") with FDA and Health Canada for Phase-2 Trial of FSD-201 f...

 fsd-pharma-closes-ca164m-sale-of-ontario-cannabis-processing-facility-heres-whats-next

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) has closed the sale of the company’s former cannabis processing facility...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated ...

 fsd-pharma-shares-slightly-up-on-agreement-to-sell-cannabis-facility-for-129m

FSD Pharma Inc.

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding c...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding co...

Core News & Articles

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION